Anti-IL27B/ IL35/ EBI3 monoclonal antibody

Anti-IL27B/ IL35/ EBI3 antibody for FACS & in-vivo assay

Target products collectionGo to IL35/EBI3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T02231-Ab-1/ GM-Tg-hg-T02231-Ab-2Anti-Human IL35/EBI3 monoclonal antibodyHuman
GM-Tg-rg-T02231-Ab-1/ GM-Tg-rg-T02231-Ab-2Anti-Rat IL35/EBI3 monoclonal antibodyRat
GM-Tg-mg-T02231-Ab-1/ GM-Tg-mg-T02231-Ab-2Anti-Mouse IL35/EBI3 monoclonal antibodyMouse
GM-Tg-cynog-T02231-Ab-1/ GM-Tg-cynog-T02231-Ab-2Anti-Cynomolgus/ Rhesus macaque IL35/EBI3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T02231-Ab-1/ GM-Tg-felg-T02231-Ab-2Anti-Feline IL35/EBI3 monoclonal antibodyFeline
GM-Tg-cang-T02231-Ab-1/ GM-Tg-cang-T02231-Ab-2Anti-Canine IL35/EBI3 monoclonal antibodyCanine
GM-Tg-bovg-T02231-Ab-1/ GM-Tg-bovg-T02231-Ab-2Anti-Bovine IL35/EBI3 monoclonal antibodyBovine
GM-Tg-equg-T02231-Ab-1/ GM-Tg-equg-T02231-Ab-2Anti-Equine IL35/EBI3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T02231-Ab-1/ GM-Tg-hg-T02231-Ab-2; GM-Tg-rg-T02231-Ab-1/ GM-Tg-rg-T02231-Ab-2;
GM-Tg-mg-T02231-Ab-1/ GM-Tg-mg-T02231-Ab-2; GM-Tg-cynog-T02231-Ab-1/ GM-Tg-cynog-T02231-Ab-2;
GM-Tg-felg-T02231-Ab-1/ GM-Tg-felg-T02231-Ab-2; GM-Tg-cang-T02231-Ab-1/ GM-Tg-cang-T02231-Ab-2;
GM-Tg-bovg-T02231-Ab-1/ GM-Tg-bovg-T02231-Ab-2; GM-Tg-equg-T02231-Ab-1/ GM-Tg-equg-T02231-Ab-2
Products NameAnti-IL35/EBI3 monoclonal antibody
Formatmab
Target NameIL35
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL35 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species IL27B/ IL35/ EBI3 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000206human EBI3 Lentivirus particle
    ORF Viral VectorpGMLV000206human EBI3 Lentivirus plasmid
    ORF Viral VectorpGMLPm000318mouse Ebi3 Lentivirus plasmid
    ORF Viral VectorvGMLPm000318mouse Ebi3 Lentivirus particle


    Target information

    Target IDGM-T02231
    Target NameIL35
    Gene ID10148,50498,680609,721832,485043,101101032,514933,100063061
    Gene Symbol and SynonymsEBI-3,EBI3,IL-27,IL-27B,IL27B,IL35B
    Uniprot AccessionQ14213
    Uniprot Entry NameIL27B_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseN/A
    Gene EnsemblENSG00000105246
    Target ClassificationCheckpoint-Immuno Oncology

    The target: IL35, gene name: EBI3, also named as IL-27B, IL27B, IL35B. This gene was identified by its induced expression in B lymphocytes in response Epstein-Barr virus infection. It encodes a secreted glycoprotein belonging to the hematopoietin receptor family, and heterodimerizes with a 28 kDa protein to form interleukin 27 (IL-27). IL-27 regulates T cell and inflammatory responses, in part by activating the Jak/STAT pathway of CD4+ T cells. [provided by RefSeq, Sep 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.